Laurence Sperling MD, FACC, FAHA, FACP

Laurence S. Sperling, M.D., FACC, FAHA, FACP is the Founder and Director of The Heart Disease Prevention Center at Emory. He is currently a Professor of Medicine (Cardiology) at the Emory University School of Medicine and a Professor of Global Health in the Hubert Department of Global Health at the Rollins School of Public Health at Emory University. Dr. Sperling serves as the current President of The American Society for Preventive Cardiology.

Dr. Sperling is originally from New York. He received his undergraduate degree from Emory College where he was accepted into Emory University School of Medicines Early Acceptance Program as a college sophomore. He graduated with his M.D. in 1989 and subsequently completed 8 additional years of training at Emory including a residency in internal medicine, a chief resident year at Emory University Hospital, an NIH-supported research fellowship in molecular and vascular medicine, and a clinical fellowship in cardiovascular diseases.

Dr. Sperling was awarded The American College of Cardiology Harry B. Graf Career Development Award for Heart Disease Prevention and The American Heart Association Council on Clinical Cardiology Scholarship for Physical Activity and Public Health in 2001.

Dr. Sperling serves or has served as medical director for a number of unique programs at Emory including The HeartWise Risk Reduction Program, InterVent Atlanta, and Staying Aloft, and has served as a special consultant to The Centers for Disease Control. He founded (in 2004) and directs the first and only LDL apheresis program in the state of Georgia. He has been voted one of America's and Atlanta's Top Doctors and appeared often on local and national TV, newspaper, radio, and magazines. In 2011 he was chosen as one of 20 national dietary experts by U.S. News and World Report to evaluate and rank America's popular diets.

He has received awards for excellence in both teachings (including the 4 Golden Apple Awards and The Deans' Teaching Award) and mentorship. He was chosen by the Dean at Emory University School of Medicine to be among the first faculty society advisors for the school's new curriculum. He had served as Associate Director of the Cardiovascular Fellowship Training program at Emory for over a decade. He has been an investigator in a number of important clinical trials including JUPITER, COURAGE, and BARI-2D, and has authored over 200 manuscripts, abstracts, and book chapters.

He is co-editor of the American College of Cardiology Diabetes Self Assessment Program, was a member of the American College of Cardiology Prevention Committee, and currently serves as Co-Chairman of the American College of Cardiology Diabetes and Cardiometabolic Working group, in addition to Chairman of the National Cardiometabolic Alliance. He also serves on the ACCs Population Health Policy and Health Promotions committee, as well as the research and publications committee of the National Diabetes Collaborative Registry. He was a member of the steering committee and moderator for the Inaugural U.S. Familial Hypercholesterolemia Summit in September 2013. Dr. Sperling is the Director of the ESCAPE CV Prevention meeting, now in its 15th year. He has delivered invited presentations on every continent except for Antarctica.